News

The provision would require "disclosure of direct and indirect compensation for brokers and consultants to employer-sponsored health plans."

Zolgensma, the first drug in the U.S. to cross the $1 million mark, is an important test for the field as a wave of gene therapies advance.

Those with an HSA-eligible high-deductible health plan will see some slightly increased contribution limits in 2020.

An Obama-era regulation that forbids discrimination based on sex has been rewritten to eliminate specific protections for LGBTQ patients.

Maine Community Health Options argues that the congressional action has no legal effect on the existence of payment obligations.

The state of Oklahoma deploys a high-risk legal strategy in a potentially precedent-setting case against opioid manufacturers.